Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Guidelines on the diagnosis and management of multiple myeloma treatment: Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular Project guidelines: Associação Médica Brasileira - 2012.
Hungria VT, Crusoe EQ, Quero AA, Sampaio M, Maiolino A, Bernardo WM. Hungria VT, et al. Among authors: crusoe eq. Rev Bras Hematol Hemoter. 2013;35(3):201-17. doi: 10.5581/1516-8484.20130050. Rev Bras Hematol Hemoter. 2013. PMID: 23904813 Free PMC article. No abstract available.
New proteasome inhibitors in the treatment of multiple myeloma.
Hungria VTM, Crusoé EQ, Bittencourt RI, Maiolino A, Magalhães RJP, Sobrinho JDN, Pinto JV, Fortes RC, Moreira ES, Tanaka PY. Hungria VTM, et al. Among authors: crusoe eq. Hematol Transfus Cell Ther. 2019 Jan-Mar;41(1):76-83. doi: 10.1016/j.htct.2018.07.003. Epub 2018 Oct 15. Hematol Transfus Cell Ther. 2019. PMID: 30793108 Free PMC article. Review.
Effect of thalidomide on bone marrow angiogenesis in multiple myeloma patients.
Cury PCC, Higashi F, Zacchi FFS, Palhares RB, Quero AA, Dias ALMS, Crusoé EQ, Hungria VTM. Cury PCC, et al. Among authors: crusoe eq. Hematol Transfus Cell Ther. 2020 Apr-Jun;42(2):159-163. doi: 10.1016/j.htct.2019.04.006. Epub 2019 Aug 10. Hematol Transfus Cell Ther. 2020. PMID: 31519532 Free PMC article.
Superiority of the triple combination of bortezomib, cyclophosphamide and dexamethasone versus cyclophosphamide, thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma, eligible for transplantation.
Crusoe EQ, Higashi F, Martinez G, Bittencourt R, Pinto Neto JV, Sousa L, Santucci R, Magalhães RJP, Colli G, Nunes RFM, Ribeiro G, Nicacio J, Zanella KR, Kutner JM, Magalhaes A, Leao D, Hallack Neto AE, Braga W, Souza EG, Guimaraes AJAM, Durigon GS, Laks D, Maiolino A, Hungria VTM; GBRAM- (GRUPO BRASILEIRO DE MIELOMA). Crusoe EQ, et al. Hematol Transfus Cell Ther. 2020 Apr-Jun;42(2):118-124. doi: 10.1016/j.htct.2019.05.004. Epub 2019 Aug 12. Hematol Transfus Cell Ther. 2020. PMID: 31537476 Free PMC article.
Managing patients with multiple myeloma during the COVID-19 pandemic: recommendations from an expert panel - ABHH monoclonal gammopathies committe.
Hungria V, Garnica M, Crusoé EQ, Magalhaes Filho RJP, Martinez G, Bittencourt R, Farias DLC, Braga WM, Neto JVP, Ribeiro GN, Maiolino A. Hungria V, et al. Among authors: crusoe eq. Hematol Transfus Cell Ther. 2020 Jul-Sep;42(3):200-205. doi: 10.1016/j.htct.2020.05.001. Epub 2020 May 13. Hematol Transfus Cell Ther. 2020. PMID: 32405620 Free PMC article.
Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. IV: CAR-T cell therapy for multiple myeloma patients.
Maiolino A, Costa LJ, Pasquini M, Crusoe EQ, Vigorito AC, Salvino MA, Seguro FS, Filho JS, Hungria VTM. Maiolino A, et al. Among authors: crusoe eq. Hematol Transfus Cell Ther. 2021 Nov;43 Suppl 2(Suppl 2):S30-S34. doi: 10.1016/j.htct.2021.09.004. Hematol Transfus Cell Ther. 2021. PMID: 34794794 Free PMC article.
Guidelines on the diagnosis and management of multiple myeloma treatment: Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular Project guidelines: Associação Médica Brasileira - 2022. Part I.
Maiolino A, Crusoé EQ, Martinez GA, Braga WMT, de Farias DLC, Bittencourt RI, Neto JVP, Ribeiro GN, Bernardo WM, Tristão L, Magalhaes RJP, Hungria VTM. Maiolino A, et al. Among authors: crusoe eq. Hematol Transfus Cell Ther. 2022 Jul-Sep;44(3):410-418. doi: 10.1016/j.htct.2022.06.003. Epub 2022 Jul 20. Hematol Transfus Cell Ther. 2022. PMID: 35970751 Free PMC article. No abstract available.
Impact of the lactate dehydrogenase in association with the International Staging System prognostic score in multiple myeloma patients treated in real life.
Viol Ferreira Lopes MA, Higashi F, Crusoe EQ, Peres ALM, Cury P, Hungria VTM. Viol Ferreira Lopes MA, et al. Among authors: crusoe eq. Hematol Transfus Cell Ther. 2023 Apr-Jun;45(2):259-265. doi: 10.1016/j.htct.2022.07.005. Epub 2022 Aug 26. Hematol Transfus Cell Ther. 2023. PMID: 36114115 Free PMC article.
COVID-19 in multiple myeloma patients: frequencies and risk factors for hospitalization, ventilatory support, intensive care admission and mortality -cooperative registry from the Grupo Brasileiro de Mieloma Multiplo (GBRAM).
Garnica M, Crusoe EQ, Ribeiro G, Bittencourt R, Magalhães RJP, Zanella KR, Hallack Neto AE, Lima JS, Solo CB, Souza EG, Fernandes AM, Maiolino A, Hungria V. Garnica M, et al. Among authors: crusoe eq. Hematol Transfus Cell Ther. 2024 Apr-Jun;46(2):153-160. doi: 10.1016/j.htct.2023.08.002. Epub 2023 Sep 13. Hematol Transfus Cell Ther. 2024. PMID: 37718131 Free PMC article.
22 results